| [1] |
Fauser BC, Tarlatzis BC, Rebar RW，et al.Consensus on women′s health aspects of polycystic ovary syndrome(PCOS)：the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group[J]．Fertil Steril，2012，97(1)：28-38.
|
| [2] |
谢幸，孔北华，段涛．妇产科学[M].9版．北京：人民卫生出版社，2018：348-350.
|
| [3] |
陶弢，王丽华．多囊卵巢综合征诊治内分泌专家共识[J]．中华内分泌代谢杂志，2018，34(1)：1-7.
|
| [4] |
Deswal R, Yadav A, Dang AS. Sex hormone binding globulin-an important biomarker for predicting PCOS risk：a systematic review and meta-analysis[J]．Syst Biol Reprod Med，2018，64(1)：12-24.
|
| [5] |
Lie Fong S, Visser JA, Welt CK, et al. Serum anti-müllerian hormone levels in healthy females：a nomogram ranging from infancy to adulthood[J]．J Clin Endocrinol Metab，2012，97(12)：4650-4655.
|
| [6] |
Durlinger AL, Gruijters MJ, Kramer P, et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary[J]．Endocrinology，2001，142(11)：4891-4899.
|
| [7] |
Dumont A, Robin G, Catteau-Jonard S，et al.Role of anti-Müllerian hormone in pathophysiology，diagnosis and treatment ofpolycystic ovary syndrome：a review[J]．Reprod Biol Endocrinol，2015(13)：137.
|
| [8] |
贺侠琴，孙桂荣，王汝琨，等．血清抗缪勒管激素与性激素联合检测对多囊卵巢综合征的诊断价值[J]．中华检验医学杂志，2018，41(6)：456-461.
|
| [9] |
Gorsic LK, Kosova G, Werstein B，et al.Pathogenic anti-müllerian hormone variants in polycystic ovary syndrome[J]．J Clin Endocrinol Metab，2017，102(8)：2862-2872.
|
| [10] |
Racine C, Genêt C, Bourgneuf C, et al. New anti-Müllerian hormone target genes involved in granulosa cell survival in women with polycystic ovary syndrome [J]．J Clin Endocrinol Metab，2020(28)：dgaa879.
|
| [11] |
Hoyos LR, Visser JA, McLuskey A，et al.Loss of anti-Müllerian hormone (AMH) immunoactivity due to a homozygous AMH gene variant rs10417628 in a woman with classical polycystic ovary syndrome (PCOS) [J]．Hum Reprod，2020，35(10)：2294-2302.
|
| [12] |
Shi Y, Li L, Zhou J，et al.Efficacy of electroacupuncture inregulating the imbalance of AMH and FSH to improve follicledevelopment and hyperandrogenism in PCOS rats[J]．Biomed Pharmacother，2019，(113)：108687.
|
| [13] |
寇丽辉，侯丽辉，孟小钰，等.300例糖尿病家族史多囊卵巢综合征患者的临床特征分析[J]．实用妇产科杂志，2018，34(11)：864-867.
|
| [14] |
Stracquadanio M, Ciotta L, Palumbo MA. Relationship between serum anti-Mullerian hormone and intrafollicular AMH levels in PCOS women[J]．Gynecol Endocrinol，2018，34(3)：223-228.
|
| [15] |
Detti L, Christiansen ME, Francillon L，et al.Serum anti-Müllerian hormone (AMH) in mothers with polycystic ovary syndrome (PCOS) and their term fetuses[J]．Syst Biol Reprod Med，2019，65(2)：147-154.
|
| [16] |
Zhang F, Liu XL, Rong N，et al.Clinical value of serum anti-mullerian hormone and inhibin B in prediction of ovarian response in patients with polycystic ovary syndrome[J]．J Huazhong Univ Sci Technolog Med Sci，2017，37(1)：70-73.
|
| [17] |
Lv PP, Jin M, Rao JP，et al.Role of anti-Müllerian hormone and testosterone in follicular growth：a cross-sectional study[J]．BMC Endocr Disord，2020，20(1)：101.
|
| [18] |
Evliyaoglu O, Imöhl M, Weiskirchen R，et al.Age-specific reference values improve the diagnostic performance of AMH in polycystic ovary syndrome[J]．Clin Chem Lab Med，2020，58(8)：1291-1301.
|
| [19] |
Sjaarda LA, Mumford SL, Kuhr DL，et al.Association of testosterone and antimüllerian hormone with time to pregnancy and pregnancy loss in fecund women attempting pregnancy[J]．Fertil Steril，2018，109(3)：540-548.
|
| [20] |
Pellatt L, Hanna L, Brincat M，et al.Granulosa cell production of anti-Müllerian hormone is increased in polycystic ovaries[J]．J Clin Endocrinol Metab，2007，92(1)：240-245.
|
| [21] |
Dai X, Wang Y, Yang H，et al. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles[J]．Sci Rep，2020，10(1)：19750.
|
| [22] |
唐婕，吴韶清，许遵鹏，等．血清抗苗勒氏管激素水平在多囊卵巢综合征患者中的诊断价值[J]．热带医学杂志，2019，19(11)：1386-1388.
|
| [23] |
Eilertsen TB, Vanky E, Carlsen SM.Anti-Mullerian hormone in the diagnosis of polycystic ovary syndrome：can morphologic description be replaced? [J]．Hum Reprod，2012，27(8)：2494-2502.
|
| [24] |
Rosenfield RL, Wroblewski K, Padmanabhan V，et al.Antimüllerian hormone levels are independently related to ovarian hyperandrogenism and polycystic ovaries[J]．Fertil Steril，2012，98(1)：242-249.
|
| [25] |
Yue CY, Lu LK, Li M，et al.Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women[J]．PLoS One，2018，13(8)：e0203129.
|
| [26] |
Shi X, Peng D, Liu Y，et al.Advantages of serum anti-müllerian hormone as a marker for polycystic ovarian syndrome[J]．Lab Med，2019，50(3)：236-242.
|
| [27] |
Vagios S, James KE, Sacha CR, et al. A patient-specific model combining antimüllerian hormone and body mass index as a predictor of polycystic ovary syndrome and other oligo-anovulation disorders[J]．Fertil Steril，2021，115(1)：229-237.
|
| [28] |
Pankhurst MW, Shorakae S, Rodgers RJ，et al.Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antimüllerian hormone isoforms (proAMH and AMHN，C)[J]．Fertil Steril，2017，108(5)：851-857.
|
| [29] |
Asanidze E, Kristesashvili J, Pkhaladze L，et al.The value of anti-Mullerian hormone in the management of polycystic ovary syndrome inadolescents[J]．Gynecol Endocrinol，2019，35(11)：974-977.
|